Mark Lackner

Insider Reports History

Entity
Individual
Location
C/O Ideaya Biosciences, Inc., 7000 Shoreline Court, Suite 350, South San Francisco, CA
Signature
/s/ Andrea Paul, attorney-in-fact for Mark Lackner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Lackner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 196K $2.26M $11.54 Feb 2, 2024 Direct
Zentalis Pharmaceuticals, Inc. Chief Scientific Officer Stock Option (Right to Buy) 141K Feb 1, 2024 Direct

Insider Reports Filed by Mark Lackner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZNTL Zentalis Pharmaceuticals, Inc. Feb 1, 2024 3 -$18.3K 4 Feb 5, 2024 Chief Scientific Officer
ZNTL Zentalis Pharmaceuticals, Inc. Jan 2, 2024 2 $0 4 Jan 3, 2024 Chief Scientific Officer
ZNTL Zentalis Pharmaceuticals, Inc. Dec 31, 2023 0 $0 3 Jan 3, 2024 Chief Scientific Officer